Home › Glioblastoma › Massachusetts › Boston
Studi clinici su Glioblastoma a Boston, MA
28 studi su Glioblastoma cercano partecipanti presso sedi a Boston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
In reclutamentoFase 2/3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
In reclutamentoFase 2
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
In reclutamentoFase 1/2
- Dana Farber Cancer Institute., Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
In reclutamentoFase 1/2
- Tufts Medical Center, Boston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
In reclutamentoFase 1
- Dana-Farber Cancer Institute, Boston
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
In reclutamentoFase 1/2
- Massachusetts General Hospital - Neurology, Boston
- Dana-Farber Cancer Institute - Oncology Department, Boston
Targeted Pediatric High-Grade Glioma Therapy
In reclutamentoStudio osservazionale
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
In reclutamento
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Olutasidenib and Temozolomide in HGG
In reclutamentoFase 2
- Susan Chi, Boston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
In reclutamentoFase 3
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
In reclutamentoFase 2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
In reclutamentoFase 2
- Dana Farber Cancer Institute, Boston
CARv3-TEAM-E T Cells in Glioblastoma
In reclutamentoFase 1
- Massachusetts General Hospital Cancer Center, Boston
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
In reclutamentoFase 2
- Dana-Farber Cancer Institute, Boston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
In reclutamentoFase 1 inizialeVolontari sani benvenuti
- Dana-Farber Cancer Institute, Boston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
In reclutamentoFase 2
- Dana-Farber Cancer Institute, Boston
G-CSF After Chemo-radiation in Patients With Glioblastoma
In reclutamentoFase 2
- Massachusetts General Hospital, Boston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
In reclutamentoFase 1/2
- Dana Farber Cancer Institute, Boston
CUE-102 in Recurrent Glioblastoma
In reclutamentoFase 1
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
In reclutamentoFase 1/2
- Dana Farber Cancer Institute, Boston
Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial
In reclutamentoFase 2
- Brigham and Women's Hospital, Boston
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
In reclutamentoFase 1 iniziale
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Massachusetts General Hospital Cancer Center, Boston
Implantable Microdevice In Primary Brain Tumors
In reclutamentoFase 1 iniziale
- Brigham and Women's Hospital, Boston
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
In reclutamentoStudio osservazionale
- Massachusetts General Hospital, Boston
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
In reclutamentoStudio osservazionale
- Massachusetts General Hospital, Boston
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
In reclutamentoStudio osservazionale
- Massachusetts General Hospital, Boston
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
In reclutamentoStudio osservazionale
- Massachusetts General Hospital, Boston
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
In reclutamentoStudio osservazionale
- Massachusetts General Hospital, Boston
Studi su Glioblastoma in altre città
- New York City, NY30 studi
- Houston, TX25 studi
- Los Angeles, CA23 studi
- Durham, NC20 studi
- San Francisco, CA17 studi
- Washington, DC15 studi
- Chicago, IL15 studi
- Rochester, MN15 studi
- Columbus, OH14 studi
- Miami, FL14 studi
- Jacksonville, FL13 studi
- Aurora, CO12 studi
Altri studi a Boston
- Cancro al seno111 studi
- Cancro del polmone non a piccole cellule90 studi
- Cancro (tutti i tipi)86 studi
- Cancro colorettale63 studi
- Cancro metastatico63 studi
- Cancro ai polmoni62 studi
- Cancro ovarico61 studi
- Cancro alla prostata59 studi
- Depressione52 studi
- Cancro dell'endometrio50 studi
- Insufficienza cardiaca44 studi
- Leucemia mieloide acuta44 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.